Charmacy Pharmaceutical Co., Ltd. provided earnings guidance for the six months ended June 30, 2016. The company's expects to record a growth of not less than 40% in the profit attributable to owners of the Company for the six months ended June 30, 2016 as compared to the corresponding period of last year. Such expected substantial growth is mainly benefited from increase in sales of goods to retail pharmacy stores; and increase in the overall gross profit margin, which was mainly due to the increase in purchase discount obtained from suppliers as a result of the increase in the company's sales of goods which acted as primary distributor.